| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $219.2M | +13.3% |
| Cost of Revenue | $97.1M | +12.1% |
| Gross Profit | $122.0M | +14.3% |
| R&D Expense | $47.6M | +6.6% |
| SG&A Expense | $39.7M | +19.1% |
| Operating Income | -$13.0M | +10.1% |
| Pre-tax Income | -$27.2M | +6.2% |
| Income Tax | $1.5M | +91.8% |
| Net Income | -$28.6M | +3.7% |
| EPS (Basic) | -$0.78 | +7.1% |
| EPS (Diluted) | -$0.78 | +7.1% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $193.5M | +17.0% |
| Accounts Receivable | $35.1M | -18.7% |
| Current Assets | $261.5M | +17.6% |
| Total Assets | $392.2M | +7.8% |
| Current Liabilities | $106.9M | +10.9% |
| Long-term Debt | $135.4M | +8.9% |
| Total Liabilities | $257.6M | +7.2% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.3M | +29.1% |
| Capital Expenditures | $993K | -5.9% |
| Investing Cash Flow | -$993K | +98.3% |
| Financing Cash Flow | $4.5M | -1.7% |
| Free Cash Flow | $24.3M | +31.1% |
| Stockholders' Equity |
| $134.6M |
| +9.0% |